Results 111 to 120 of about 40,310 (216)

Emergence of double- and triple-gene reassortant G1P[8] rotaviruses possessing a DS-1-like backbone after rotavirus vaccine introduction in Malawi [PDF]

, 2018
To combat the high burden of rotavirus gastroenteritis, multiple African countries have introduced rotavirus vaccines into their childhood immunization programs.
Bar-Zeev, N, Beard, J, Bennett, A, Chaguza, C, Costello, A, Crampin, AC, Cunliffe, NA, French, N, Heyderman, RS, Iturriza-Gomara, M, Jere, KC, King, C, Kumwenda, B, Lewycka, S, Lowe, J, Mvula, H, Mwansambo, C, Nakagomi, O, Parashar, UD, Peno, C, Phiri, T, Pollock, L, Tate, JE, Verani, JR, Whitney, CG   +24 more
core  

Prevalence and molecular epidemiology of rotavirus gastroenteritis among children in Nairobi’s urban informal settlements following introduction of the Rotavac® vaccine

Tropical Medicine and Health
Background Rotavirus is the leading cause of acute gastroenteritis among children under five years of age globally. In Kenya, rotavirus vaccination was introduced in 2014 using Rotarix® (G1P[8]), with a subsequent national transition to Rotavac® (G9P[11])
Winfred Mbithi, Ernest A. Wandera, Anthony K. Nyamache, Daniel Hungerford, Amos Njuguna, Michael Mugo, Aoko Johnpaul Ogutha, Christine Kioko, Darius Ideke, Carlene Sang, James Nyangao, Phelgona Otieno, Fredrick Were, Khuzwayo C. Jere, Nigel A. Cunliffe, Samuel Kariuki, Cecilia Mbae   +16 more
doaj   +1 more source

Masa Depan Vaksin Rotavirus di Indonesia [PDF]

, 2014
Rotavirus adalah penyebab utama gastroenteritis pada anak-anak. Insiden diare yang disebabkan rotavirus di Indonesia terjadi sepanjang tahun dengan jumlah kematian mencapai sekitar 10.088 anak per tahun.
Pangesti, K. N. (Krisna), Setiawaty, V. (Vivi)   +1 more
core  

Rotavirus Vaccines

Korean Journal of Pediatric Infectious Diseases, 1999
E, Gault, A, Garbarg-Chenon
openaire   +3 more sources

Accounting for local incidence when estimating rotavirus vaccine efficacy among countries: a pooled analysis of monovalent rotavirus vaccine trials. [PDF]

Am J Epidemiol
Amin AB, Waller LA, Tate JE, Lash TL, Lopman BA.   +4 more
europepmc   +1 more source

Peripheral rotavirus-specific T-cell responses following monovalent oral rotavirus vaccine in infants. [PDF]

NPJ Vaccines
Nicols AR, Lee Y, Congrave-Wilson Z, Kim M, Cheng WA, Jumarang J, Navarro J, Navarro R, Rodriguez-Angeles Y, Durand D, Taylor ZW, De León RG, Ochoa TJ, Sette A, da Silva Antunes R, Pannaraj PS.   +15 more
europepmc   +1 more source

Diarrhoea events in offspring exposed to tumour necrosis factor inhibitors and rotavirus vaccine: a population-based cohort study. [PDF]

Rheumatology (Oxford)
Flatman LK, Beauchamp ME, St-Pierre Y, Malhamé I, Bérard A, Bernatsky S, Vinet É.   +6 more
europepmc   +1 more source

Design and immunogenicity of a recombinant Saccharomyces boulardii secreting the P2-VP8 subunit rotavirus vaccine. [PDF]

Sci Rep
Farhani I, Yamchi A, Nikoo HR, Shamsabadi FT, Abdoli S, Cheng RH, Shahbazi M.   +6 more
europepmc   +1 more source

Oral rotavirus vaccine effectiveness among malnourished children in 19 countries: Findings from the MNSSTER-V project. [PDF]

J Pediatr Gastroenterol Nutr
Burnett E, Ticklay I, Umana J, Mandomando I, Robinson AL, Omore R, Goldfarb DM, Safi N, Trang NV, Kisakye A, Uwimana J, N'Zue K, Groome MJ, Enweronu-Laryea C, Bonkoungou I, Iniguez V, McCracken J, Lungayo CL, Michael F, Sahakyan G, Rey-Benito G, Weldegebriel G, Mwenda JM, Parashar UD, Tate JE, Multi‐national Subpopulations Study to Evaluate Rotavirus Vaccines (MNSSTER‐V) Project Working Group.   +25 more
europepmc   +1 more source

Impact of the indigenous rotavirus vaccine Rotavac in the Universal Immunization Program in India during 2016-2020. [PDF]

Nat Med
Nair NP, Reddy SN, Giri S, Varghese T, Thiyagarajan V, Muliyil J, Hemavathy P, Khakha SA, Arora R, Gupte MD, Tate JE, Parashar UD, Mohan VR, Kang G, Collaborators of the rotavirus vaccine effectiveness and impact assessment network.   +14 more
europepmc   +1 more source